Pfizer (PFE) News Today → Nvidia CEO Says It Will Be “the Next Revolution” Beyond AI (From Banyan Hill Publishing) (Ad) Free PFE Stock Alerts $25.65 +0.25 (+0.98%) (As of 04/29/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineVan ECK Associates Corp Raises Position in Pfizer Inc. (NYSE:PFE)marketbeat.com - April 29 at 8:49 PMThese 3 High-Yield Stocks Have Been Growing Their Dividends Non-Stop, And Analysts Expect Their Share Prices To Climbfinance.yahoo.com - April 29 at 6:46 PMUPDATE 1-US FDA grants full approval for Pfizer's cervical cancer drugfinance.yahoo.com - April 29 at 6:46 PMFDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancerfinance.yahoo.com - April 29 at 6:46 PMTIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancerfinance.yahoo.com - April 29 at 6:46 PMFDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancerbusinesswire.com - April 29 at 6:40 PMTIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancerbusinesswire.com - April 29 at 6:40 PMTIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancerglobenewswire.com - April 29 at 6:40 PMUS FDA grants full approval for Pfizer's cervical cancer drugreuters.com - April 29 at 4:09 PMPfizer (NYSE:PFE) Trading Up 1.3%marketbeat.com - April 29 at 3:17 PMThese Pharmaceutical Firms Are On Sale: Abbvie, Pfizer, And Gileadmsn.com - April 29 at 1:46 PMPfizer gene therapy made in NC gets FDA approval. It costs $3.5M per dosebizjournals.com - April 29 at 1:46 PM3 Ultra-Yield Dividend Stocks Retirees Can Trust247wallst.com - April 29 at 10:20 AMLabcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia Bprnewswire.com - April 29 at 7:09 AMPfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meetingbusinesswire.com - April 29 at 6:45 AM3 Dividend Stocks to Buy on the Dip: April 2024investorplace.com - April 29 at 6:00 AMRaymond James & Associates Raises Position in Pfizer Inc. (NYSE:PFE)marketbeat.com - April 28 at 10:53 PMThe Motley Fool: Pfizer offers a pfat 6.4% dividenddallasnews.com - April 28 at 2:54 PM5 Of The Highest Yielding Blue Chip Stocks To Buy Now247wallst.com - April 28 at 7:45 AM3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Streetfool.com - April 28 at 5:50 AMPfizer (NYSE:PFE) Stock Price Up 0.3%americanbankingnews.com - April 28 at 3:18 AMPfizer Inc. (NYSE:PFE) Receives Consensus Rating of "Hold" from Analystsamericanbankingnews.com - April 28 at 2:28 AMPfizer (NYSE:PFE) Sets New 12-Month Low at $25.20americanbankingnews.com - April 28 at 1:52 AMPfizer Inc. (PFE)finance.yahoo.com - April 27 at 11:37 PMPfizer gets FDA approval for hemophilia B gene therapy Beqvezmsn.com - April 27 at 11:37 PMPFG Investments LLC Raises Stock Holdings in Pfizer Inc. (NYSE:PFE)marketbeat.com - April 27 at 10:17 PM3 Dividend Stocks to Buy and Hold for the Next Decadefool.com - April 27 at 7:15 AM7 Dividend Stocks to Buy Now for Steady Returns in Any Marketinvestorplace.com - April 27 at 6:00 AMPfizer’s First Gene Therapy Gets Approval for Clotting Disorderbloomberg.com - April 26 at 10:34 PMPfizer (NYSE:PFE) Notches Up on New FDA Approvalmsn.com - April 26 at 10:34 PMStanley Laman Group Ltd. Buys 44,722 Shares of Pfizer Inc. (NYSE:PFE)marketbeat.com - April 26 at 9:14 PMWhat Factors Will Drive Pfizer's Q1 Performance?forbes.com - April 26 at 5:34 PMPfizer Wins FDA Approval For $3.5 Million Gene Therapy, Rivaling CSL, Uniqurefinance.yahoo.com - April 26 at 5:34 PMFDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophiliafinance.yahoo.com - April 26 at 5:34 PMPfizer (NYSE:PFE) Sets New 52-Week Low at $25.20marketbeat.com - April 26 at 2:35 PMPfizer Gains as Gene Therapy Wins FDA Nodbaystreet.ca - April 26 at 12:33 PMPfizer Receives FDA Approval for Bleeding Disorder Treatmentbarrons.com - April 26 at 9:35 AMWant $2,000 in Annual Dividends? Invest $30,000 in These 3 Stocksfool.com - April 26 at 7:45 AMPfizer Gets FDA OK For Beqvez Gene Therapy for Hemophilia Bmarketwatch.com - April 26 at 7:33 AMPfizer's Beqvez Receives FDA Approval For Treatment Of Adults With Hemophilia Bmarkets.businessinsider.com - April 26 at 7:33 AMUS FDA approves Pfizer's gene therapy for rare bleeding disorderreuters.com - April 26 at 7:33 AMU.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia Bfinance.yahoo.com - April 26 at 7:33 AMPfizer Now Rivals The World's Most Expensive Medicine After FDA Approves Gene Therapyfinance.yahoo.com - April 26 at 7:33 AMUPDATE 2-US FDA approves Pfizer's gene therapy for rare bleeding disorderfinance.yahoo.com - April 26 at 7:33 AMFDA approves Pfizer's first gene therapy for rare inherited bleeding disordercnbc.com - April 26 at 7:02 AMU.S. FDA Approves Pfizer's BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia Bbusinesswire.com - April 26 at 6:45 AMPfizer (NYSE:PFE) Trading Down 2.5%marketbeat.com - April 25 at 6:18 PMSyon Capital LLC Boosts Stock Position in Pfizer Inc. (NYSE:PFE)marketbeat.com - April 25 at 5:33 PM3 Bargain Stocks Near 52-week Lowsmarketbeat.com - April 25 at 9:46 AM3 Bargain Stocks Near 52-week Lows (PFE)marketbeat.com - April 25 at 9:46 AM Get Pfizer News Delivered to You Automatically Sign up to receive the latest news and ratings for PFE and its competitors with MarketBeat's FREE daily newsletter. Email Address Nvidia CEO Says It Will Be “the Next Revolution” Beyond AI (Ad)Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it. Click on Adam's shiny forehead for more details. PFE Media Mentions By Week PFE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PFE News Sentiment▼0.480.34▲Average Medical News Sentiment PFE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PFE Articles This Week▼6433▲PFE Articles Average Week Get Pfizer News Delivered to You Automatically Sign up to receive the latest news and ratings for PFE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Bristol-Myers Squibb News Zoetis News AbbVie News Merck & Co., Inc. News Johnson & Johnson News Sanofi News Abbott Laboratories News Vertex Pharmaceuticals News Novartis News Regeneron Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:PFE) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingCharles Payne’s Gift to Stock InvestorsUnstoppable ProsperityHe Is Giving Away BitcoinCrypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pfizer Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
